LONDON, Aug. 27, 2020
Forecasts by Therapeutics (Cancer, Cardiovascular, Central Nervous System, Infectious Diseases, Immunology, Others), by Technology (Companion Diagnostics, Biomarkers, Biobanking in Targeted Therapeutics, Pharmacogenomics, Molecular Diagnostics), by End Users (Pharma & Biotech, Diagnostic Tool Companies, Healthcare IT/Big Data Companies, Clinical Laboratories), Profiles of Leading Companies and Regional and Leading National Market Analysis
LONDON, Aug. 27, 2020 /PRNewswire/ -- Precision Medicine–our new study reveals trends, R&D progress, and predicted revenues
Where is the Precision Medicine market heading? If you are involved in this sector you must read this newly updated report. Visiongain's report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 375 pages report provides 271 tables, 267 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Precision Medicine Market. See how to exploit the opportunities.
This Visiongain report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.
Forecasts to 2030 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
To request sample pages from this report please email email@example.com or refer to our website: https://www.visiongain.com/report/precision-medicine-market-report-2020-2030/#download_sampe_div
Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are following segments, each forecasted at a global and regional level.
Precision Medicine Market by Therapeutics
• Central Nervous System
• Infectious Diseases
Precision Medicine Market by Technology
• Companion Diagnostics
• Biobanking in Targeted Therapeutics
• Molecular Diagnostics
Precision Medicine Market by End Users
• Pharma & Biotech
• Diagnostic Tool Companies
• Healthcare IT/Big Data Companies
• Clinical Laboratories
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 22 leading national markets:
• Rest of Europe
• The Philippines
• South Korea
• Rest of Asia Pacific
• Rest of Latin America
Middle East and Africa
• Saudi Arabia
• South Africa
• Rest of MEA
The report also includes profiles and for some of the leading companies in the Precision Medicine market, with a focus on this segment of these companies' operations.
Leading companies and the potential for market growth
Overall world revenue for Precision Medicine Market will surpass $67 billion in 2020, our work calculates. We predict strong revenue growth through to 2030.
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Precision Medicine Market report helps you
In summary, our 375 pages report provides you with the following knowledge:
• Revenue forecasts to 2030 for 5 regional and 22 key national markets– See forecasts for the Precision Medicine market in North America, Latin America, Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Argentina, Germany, France, UK, Italy, Spain, Belgium, Switzerland, China, India, Japan, Australia, Singapore, The Philippines, South Korea. UAE, Saudi Arabia and South Africa.
• Prospects for established firms and those seeking to enter the market– including company profiles for 14 of the major companies involved in the Precision Medicine market i.e. Abbott, GE Healthcare, Johnson & Johnson Services, Inc., Pfizer Inc., Laboratory Corporation of America Holdings, Danaher, Qiagen N.V., Thermo Fisher Scientific Inc., Illumina, Inc., Novartis AG, GSK, Merck KGaA, F. Hoffmann-La Roche Ltd, and Amgen Inc.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
To request a report overview of this report please email firstname.lastname@example.org or refer to our website: https://www.visiongain.com/report/precision-medicine-market-report-2020-2030/
Did you know that we also offer a report add-on service? Email email@example.com to discuss any customized research needs you may have.
Companies covered in the report include:
F. Hoffmann-La Roche Ltd
Johnson & Johnson Services, Inc.
Laboratory Corporation of America Holdings
Thermo Fisher Scientific Inc.
American Association for Cancer Research (AACR)
American Medical Association
American National Standards Institute (ANSI)
American Telemedicine Association
Association for Molecular Pathology
Beth Israel Deaconess Medical Center (BIDMC)
Biobank Japan-Riken Institute
Biobanque de Picardie
Biological Resources Centres
Canadian Biosample Repository
Canadian Federal Government
Canadian Institutes of Health Research (CIHR)
Cancer Research Network of the FRSQ
Capital Health/Regional Tissue Bank
Careggi University Hospital
Central Biomaterial Bank
Centre for Disease Control and Prevention (CDC)
Confederation of Cancer Biobanks
Danubian Biobank Consortium Tissue Bank
Drug Enforcement Agency (DEA)
European Association for Cancer Research (EACR)
European Diagnostics Manufacturers Association (EDMA)
European Federation of Pharmaceutical Industries and Associations (EFPIA)
European Medicines Agency (EMA)
European Society of Human Genetics
Food and Drug Administration (FDA)
Genethon DNA and Cell Bank
German Heart Failure Network
Global Medical Technology Alliance (GMTA)
Health Science Research Resources Bank/Japan Health Science Foundation
Healthcare information and management systems society (HIMSS)
International Human Genome Sequencing Consortium
International Medical Device Regulators Forum (IMDRF)
Japan National Cancer Center Brain Bank for Aging Research
Japanese Collection of Research Bioresources
King's College Infectious Diseases Biobank
Liverpool Tissue Bank
Manitoba Breast Tumour Bank
National Institutes of Health (NIH)
NHS Cod Blood Bank
Norwegian University of Science and Technology
Office of the national coordinator for health information technology (ONC HIT)
Ohio State University
Ontario Cancer Research Network
Organization of European Cancer Institute (OECI)
Patient DNA collection at Institute of Human Genetics Heidelberg
Patient-Centered Outcomes Research Institute (PCORI)
Pharmaceutical and medical devices agency (PMDA)
PROCURE Quebec Prostate Cancer
Southwest France Tumour Bank
The Brain Tumour Tissue Bank
The Center for Assessment Technology and Continuous Health (CATCH)
The National Center for Toxicological Research (NCTR)
The National Health Services (NHS)
The National Institute for Health Research (NIHR)
Therapeutic Goods Administration (TGA)
Triangle Global Health Consortium
Tumour Bank of Provence
U.K. Biobank Roslin Wellcome Trust Tick Cell Biobank
U.K. DNA Banking Network
U.K. Stem Cell Bank
United Kingdom Clinical Research Network (UKCRN)
University Hospital of Lausanne and University of Lausanne
University of Bristol
University of Massachusetts Medical School
University of Tartu
Wireless-Life Sciences Alliance (WLSA)
World Health Organization (WHO)
To see a report overview please e-mail firstname.lastname@example.org